Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions (Details Narrative)

v3.22.2.2
Related Party Transactions (Details Narrative)
9 Months Ended
Sep. 30, 2022
Tactic Pharma LLC  
Beneficial Ownership 33.30%